鲜益母草胶囊治疗产后宫腔积血临床价值分析

Fresh motherwort capsule treatment of postpartum uterine hemorrhage clinical value analysis

目的分析鲜益母草胶囊治疗产后宫腔积血临床价值。方法以北京市上地医院2016年1月~2016年12月收治的100例产后宫腔积血患者为研究对象,对照组采用缩宫素治疗,观察组采用鲜益母草胶囊联合缩宫素进行治疗。检查患者用药治疗后的子宫复旧情况与临床疗效情况。结果产后5 d时,2组患者的产后子宫复旧情况接近,差异无统计学意义。产后14 d,观察组患者的子宫复旧情况显著比对照组好,差异有统计学意义（P〈0.05）;观察组患者治疗的治愈率（76.0%）和治疗总有效率（96.0%）均显著比对照组（56.0%,88.0%）高,差异具有统计学意义（P〈0.05）。结论鲜益母草胶囊在产后宫腔积血治疗方面具有显著的临床疗效,能促进患者的子宫复旧,具有重大的临床价值,值得进行推广应用。

Objective To analysis the fresh motherwort capsule treatment of postpartum uterine hemorrhage clinical value.Methods100 cases of postpartum uterine hemorrhage patients of our hospital from January 2016 to December 2016 were selected as the research object, the control treatment, use contractions observed group of using fresh motherwort capsule combined contractions for treatment.Check after drug treatment in patients with uterine instauration and clinical curative effect.ResultsAfter five days, two groups of patients with postpartum uterine instauration is close, there was no statistically significant difference.After 14 days, observation group of patients with uterine instauration was significantly better than the control group, there was statistically significant difference （P〈 0.05）;Observation group of patients treatment of cure rate （76.0%）, and total effective rate （96.0%） were significantly higher than control group （56.0%, 88.0%）, statistically significant difference （P〈 0.05）.ConclusionFresh motherwort capsule in the treatment of postpartum uterine hemorrhage has significant clinical efficacy, can promote the patients with uterine instauration, has significant clinical value, worthy of popularization and application.